Caribou Biosciences: H.C. Wainwright cuts to neutral from buy
CRBU•H.C. Wainwright cut its rating on Caribou Biosciences to neutral from buy.
Related News
SPAR Canada, ReposiTrak launch Touchless Retail merchandising program in Canada
TRAK•
Forum Markets raises target price to $13 from $11
FRMM•
EV maker Polestar logs slightly higher quarterly sales as US ban looms
PSNY•
Twin Vee amends USFM merger terms, boosts USFM holders’ stake to 93%
VEEE•
Venture Global says ICC issued partial final award in VGCP-GALP LNG arbitration
VG•